Literature DB >> 28555542

Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes.

Sarah Lumley1,2,3, Daniel L Horton2, Luis L M Hernandez-Triana1, Nicholas Johnson2,1, Anthony R Fooks1,4,5, Roger Hewson3,5.   

Abstract

Rift Valley fever virus (RVFV) is a mosquito-borne arbovirus causing severe disease in humans and ruminants. Spread of RVFV out of Africa has raised concerns that it could emerge in Europe or the USA. Virus persistence is dependent on successful infection of, replication in, and transmission to susceptible vertebrate and invertebrate hosts, modulated by virus-host and vector-virus interactions. The principal accepted theory for the long-term maintenance of RVFV involves vertical transmission (VT) of virus to mosquito progeny, with the virus surviving long inter-epizootic periods within the egg. This VT hypothesis, however, is yet to be comprehensively proven. Here, evidence for and against the VT of RVFV is reviewed along with the identification of factors limiting its detection in natural and experimental data. The observations of VT for other arboviruses in the genera Alphavirus, Flavivirus and Orthobunyavirus are discussed within the context of RVFV. The review concludes that VT of RVFV is likely but that current data are insufficient to irrefutably prove this hypothesis.

Entities:  

Mesh:

Year:  2017        PMID: 28555542     DOI: 10.1099/jgv.0.000765

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  A protective bivalent vaccine against Rift Valley fever and bluetongue.

Authors:  Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Julio Benavides; Aitor Nogales; Rafael Blasco; Alejandro Brun; Javier Ortego
Journal:  NPJ Vaccines       Date:  2020-07-30       Impact factor: 7.344

2.  Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo.

Authors:  Georges Mbuyi Tshilenge; William G Dundon; Marco De Nardi; Leopold K Mulumba Mfumu; Mark Rweyemamu; Jean-Marie Kayembe-Ntumba; Justin Masumu
Journal:  Trop Anim Health Prod       Date:  2018-10-22       Impact factor: 1.559

Review 3.  Molecular aspects of Rift Valley fever virus and the emergence of reassortants.

Authors:  Natasha N Gaudreault; Sabarish V Indran; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Virus Genes       Date:  2018-11-13       Impact factor: 2.332

4.  Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors.

Authors:  Mubarak A Alamri; Muhammad Usman Mirza; Muhammad Muzammal Adeel; Usman Ali Ashfaq; Muhammad Tahir Ul Qamar; Farah Shahid; Sajjad Ahmad; Eid A Alatawi; Ghadah M Albalawi; Khaled S Allemailem; Ahmad Almatroudi
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

5.  An unusually long Rift valley fever inter-epizootic period in Zambia: Evidence for enzootic virus circulation and risk for disease outbreak.

Authors:  Herman M Chambaro; Kazuyo Hirose; Michihito Sasaki; Brigadier Libanda; Yona Sinkala; Paul Fandamu; Walter Muleya; Fredrick Banda; Joseph Chizimu; David Squarre; Misheck Shawa; Yongjin Qiu; Hayato Harima; Yuki Eshita; Edgar Simulundu; Hirofumi Sawa; Yasuko Orba
Journal:  PLoS Negl Trop Dis       Date:  2022-06-02

Review 6.  Animal board invited review: Risks of zoonotic disease emergence at the interface of wildlife and livestock systems.

Authors:  François Meurens; Charlotte Dunoyer; Christine Fourichon; Volker Gerdts; Nadia Haddad; Jeroen Kortekaas; Marta Lewandowska; Elodie Monchatre-Leroy; Artur Summerfield; Paul J Wichgers Schreur; Wim H M van der Poel; Jianzhong Zhu
Journal:  Animal       Date:  2021-06-03       Impact factor: 3.240

Review 7.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

8.  First Serological Evidence of Crimean-Congo Hemorrhagic Fever Virus and Rift Valley Fever Virus in Ruminants in Tunisia.

Authors:  Khaoula Zouaghi; Ali Bouattour; Hajer Aounallah; Rebecca Surtees; Eva Krause; Janine Michel; Aymen Mamlouk; Andreas Nitsche; Youmna M'ghirbi
Journal:  Pathogens       Date:  2021-06-18

9.  A protective bivalent vaccine against Rift Valley fever and bluetongue.

Authors:  Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Julio Benavides; Aitor Nogales; Rafael Blasco; Alejandro Brun; Javier Ortego
Journal:  NPJ Vaccines       Date:  2020-07-30       Impact factor: 7.344

10.  Competence of mosquitoes native to the United Kingdom to support replication and transmission of Rift Valley fever virus.

Authors:  Sarah Lumley; Luis M Hernández-Triana; Daniel L Horton; Maria Del Mar Fernández de Marco; Jolyon M Medlock; Roger Hewson; Anthony R Fooks; Nicholas Johnson
Journal:  Parasit Vectors       Date:  2018-05-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.